Interpace Biosciences
IDXG
#11365
Rank
N/A
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Interpace Biosciences (IDXG) - Cash on Hand

Cash on Hand as of June 2026 : A$3.82 Million

According to Interpace Biosciences's latest financial reports the company has A$3.82 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Interpace Biosciences - Cash on Hand chart (from 1997 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31A$3.73 M59.22%
2024-12-31A$2.34 M-54.25%
2023-12-31A$5.13 M-27.63%
2022-12-31A$7.09 M92.5%
2021-12-31A$3.68 M2.24%
2020-12-31A$3.6 M8.75%
2019-12-31A$3.31 M-61.51%
2018-12-31A$8.61 M-55.76%
2017-12-31A$19.46 M2231.11%
2016-12-31A$0.83 M-92.77%
2015-12-31A$11.55 M-59.28%
2014-12-31A$28.37 M-44.68%
2013-12-31A$51.28 M0.79%
2012-12-31A$50.88 M-19.07%
2011-12-31A$62.87 M1.6%
2010-12-31A$61.88 M-23.46%
2009-12-31A$80.84 M-36.79%
2008-12-31A$0.12 B4.52%
2007-12-31A$0.12 B-15.89%
2006-12-31A$0.14 B9.03%
2005-12-31A$0.13 B-5.7%
2004-12-31A$0.14 B-8.25%
2003-12-31A$0.15 B19.58%
2002-12-31A$0.12 B-60.69%
2001-12-31A$0.32 B61.03%
2000-12-31A$0.20 B125%
1999-12-31A$90.54 M-6.66%
1998-12-31A$97.01 M989.7%
1997-12-31A$8.9 M